Serum Urate Monitoring Among Older Adults With Gout: Initiating Urate‐Lowering Therapy in Ontario, Canada

Author:

Kwok Timothy S. H.1ORCID,Kuriya Bindee1ORCID,Hawker Gillian2ORCID,Li Ping3,Choy Gregory4,Widdifield Jessica5ORCID

Affiliation:

1. University of Toronto Toronto Ontario Canada

2. University of Toronto and Women's College Hospital Toronto Ontario Canada

3. ICES Toronto Ontario Canada

4. University of Toronto and Sunnybrook Research Institute Toronto Ontario Canada

5. University of Toronto, ICES, and Sunnybrook Research Institute Toronto Ontario Canada

Abstract

ObjectiveTo assess the proportion of, and factors associated with, older adults with gout receiving a serum urate (SUA) test after starting urate‐lowering therapy (ULT).MethodsWe performed a population‐based retrospective cohort study in Ontario, Canada in patients ages ≥66 years with gout, newly dispensed ULT between 2010 and 2019. We characterized patients with SUA testing within 6 and 12 months after ULT dispensation. Multilevel logistic regression clustered by ULT prescriber evaluated the factors associated with SUA monitoring within 6 months.ResultsWe included 44,438 patients with a mean ± SD age of 76.0 ± 7.3 years and 64.4% male. Family physicians prescribed 79.1% of all ULTs. SUA testing was lowest in 2010 (56.4% at 6 months) and rose over time to 71.3% in 2019 (P < 0.0001). Compared with rheumatologists, family physicians (odds ratio [OR] 0.26 [95% confidence interval (95% CI) 0.23–0.29]), internists (OR 0.34 [95% CI 0.29–0.39]), nephrologists (OR 0.37 [95% CI 0.30–0.45]), and other specialties (OR 0.25 [95% CI 0.21–0.29]) were less likely to test SUA, as were male physicians (OR 0.87 [95% CI 0.83–0.91]). Patient factors associated with lower odds of SUA monitoring included rural residence (OR 0.81 [95% CI 0.77–0.86]), lower socioeconomic status (OR 0.91 [95% CI 0.85–0.97]), and patient comorbidities. Chronic kidney disease, hypertension, diabetes mellitus, and coprescription of colchicine/oral corticosteroids (OR 1.31 [95% CI 1.23–1.40]) were correlated with increased SUA testing.ConclusionSUA testing is suboptimal among older adults with gout initiating ULT but is improving over time. ULT prescriber, patient, and prescription characteristics were correlated with SUA testing.

Funder

Sunnybrook Foundation

Publisher

Wiley

Subject

Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3